From Looksmaxxing to FDA Approval? The U.S. Considers Greenlighting Mystery Peptides FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be FDA Peptide Reclassification 2026: What Researchers Want